2017 ACC/AHA Hypertension Guidelines: Case Study

Article

Click through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.

The new guidelines on management of hypertension in adults, developed by the American College of Cardiology and American Heart Association, in collaboration with 9 other professional organizations, offer clinicians and patients alike an opportunity to help reduce the incidence, prevalance and public health impact of high blood pressure (BP) in the United States.

This short slide show provides a simple illustration of the revised guidelines' key principles: accurate BP measurement, a new BP classification system, a lower BP target value, a renewed emphasis on lifestyle modification during treatment, and incorporation of underlying cardiovascular risk into decisions on pharmacotherpay.

 

 

 

 

 

 

 

 

 

 

 

 

Resources

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2017; DOI:10.1161/HYP.0000000000000066

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; DOI:10.1016/j.jacc.2017.11.005.

Muntner P, Carey RM, Gidding S, et al. Potential US population impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Circulation 2017; DOI:10.1161/CIRCULATIONAHA.117.032582.

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
A panel of 5 cardiovascular experts
Video 5 - "Real-World Insights: Navigating Cardiac Myosin inhibitors in Practice" - Featuring 1 KOL
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
© 2024 MJH Life Sciences

All rights reserved.